

Renal Cell Carcinoma (RCC)

A Web site for patients and caregivers with information on SUTENT® (sunitinib malate), RCC,
and First Resource®, a comprehensive reimbursement support and patient assistance program
sponsored by Pfizer Oncology.

A website for patients and caregivers offering information and resources on treatment
with TORISEL® (temsirolimus) injection, RCC, and TORISEL coverage and reimbursement support.

This easy-to-use online tool allows patients and caregivers to create their own
customized TORISEL guide covering the topics they find most helpful, including
information about TORISEL treatment, patient assistance and support, and RCC.

This guide will help your patients understand RCC and provide information on its
causes, stages, and treatments.
When you click on an item, it will open in a new window.
In order to view these PDF documents, you must have Adobe® Reader® installed
on your computer. If you do not have Adobe Reader, download it from the Adobe Web site.
Note that the Adobe Web site is neither owned nor controlled by Pfizer. Pfizer is not responsible for the content or services on that site.
Adobe, the Adobe logo, and Reader are registered trademarks of Adobe Systems Incorporated in the United States and/or other countries.